Peptide receptors as molecular targets for cancer diagnosis and therapy.

By J. Reubi. Endocrine reviews, 2003

1,102 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/18c3a6f8bcc7755f838813dfafb3222047450c6d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. Xiaoyuan Chen

Citations in the corpus

• Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. (2011, background): “express subtypes of the somatostatin receptor family.(1) This feature allows treatment with the somatostatin analog octreotide LAR,(2,3) facilitates receptor imaging with radiolabeled somatostatins,(4) and pro-”
• Peptide-based Probes for Targeted Molecular Imaging (2010, background): “Li ZB, Wu Z, Chen K, Ryu EK, Chen X. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging.”